Onderneming Bright Minds Biosciences Inc.
Aandelen
DRUG
CA10919W4056
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,38 CAD | +1,47% |
|
0,00% | -34,91% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ian McDonald
FOU | Founder | 37 | 31-05-19 |
Ryan Cheung
DFI | Director of Finance/CFO | 45 | 29-05-20 |
Jan Pedersen
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-04-22 |
Mark A. Smith
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-12-22 |
Gideon Shapiro
PRN | Corporate Officer/Principal | 64 | 29-09-20 |
Thomas Lategan
LAW | General Counsel | 65 | 14-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ian McDonald
FOU | Founder | 37 | 31-05-19 |
David Weiner
BRD | Director/Board Member | 59 | 17-02-23 |
Jeremy Fryzuk
BRD | Director/Board Member | 39 | 29-09-20 |
Nils Bottler
BRD | Director/Board Member | 37 | 29-09-20 |
Jan Pedersen
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 463 837 | 2 880 112 ( 64,52 %) | 0 | 64,52 % |
Bedrijfsgegevens
![Adres Bright Minds Biosciences Inc.(DRUG)](https://cdn.zonebourse.com/static/address/118740053.png)
Sector
Chiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-34,91% | 4,5 mln. | |
+19,41% | 45,51 mld. | |
-8,62% | 38,52 mld. | |
+38,65% | 38,13 mld. | |
+26,95% | 30,74 mld. | |
-13,50% | 26,03 mld. | |
+10,74% | 25,92 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. |
- Beurs
- Aandelen
- Koers DRUG
- Onderneming Bright Minds Biosciences Inc.